These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 26590367

  • 1. The MAO-B inhibitor deprenyl reduces the oral tremor and the dopamine depletion induced by the VMAT-2 inhibitor tetrabenazine.
    Podurgiel SJ, Yohn SE, Dortche K, Correa M, Salamone JD.
    Behav Brain Res; 2016 Feb 01; 298(Pt B):188-91. PubMed ID: 26590367
    [Abstract] [Full Text] [Related]

  • 2. The vesicular monoamine transporter (VMAT-2) inhibitor tetrabenazine induces tremulous jaw movements in rodents: implications for pharmacological models of parkinsonian tremor.
    Podurgiel SJ, Nunes EJ, Yohn SE, Barber J, Thompson A, Milligan M, Lee CA, López-Cruz L, Pardo M, Valverde O, Lendent C, Baqi Y, Müller CE, Correa M, Salamone JD.
    Neuroscience; 2013 Oct 10; 250():507-19. PubMed ID: 23867769
    [Abstract] [Full Text] [Related]

  • 3. Fluoxetine Administration Exacerbates Oral Tremor and Striatal Dopamine Depletion in a Rodent Pharmacological Model of Parkinsonism.
    Podurgiel SJ, Milligan MN, Yohn SE, Purcell LJ, Contreras-Mora HM, Correa M, Salamone JD.
    Neuropsychopharmacology; 2015 Aug 10; 40(9):2240-7. PubMed ID: 25759301
    [Abstract] [Full Text] [Related]

  • 4. Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo.
    Lamensdorf I, Youdim MB, Finberg JP.
    J Neurochem; 1996 Oct 10; 67(4):1532-9. PubMed ID: 8858937
    [Abstract] [Full Text] [Related]

  • 5. Induction of oral tremor in mice by the acetylcholinesterase inhibitor galantamine: Reversal with adenosine A2A antagonism.
    Podurgiel SJ, Spencer T, Kovner R, Baqi Y, Müller CE, Correa M, Salamone JD.
    Pharmacol Biochem Behav; 2016 Jan 10; 140():62-7. PubMed ID: 26459156
    [Abstract] [Full Text] [Related]

  • 6. Partial reversal of the effort-related motivational effects of tetrabenazine with the MAO-B inhibitor deprenyl (selegiline): Implications for treating motivational dysfunctions.
    Contreras-Mora H, Rowland MA, Yohn SE, Correa M, Salamone JD.
    Pharmacol Biochem Behav; 2018 Mar 10; 166():13-20. PubMed ID: 29309800
    [Abstract] [Full Text] [Related]

  • 7. Not All Antidepressants Are Created Equal: Differential Effects of Monoamine Uptake Inhibitors on Effort-Related Choice Behavior.
    Yohn SE, Collins SL, Contreras-Mora HM, Errante EL, Rowland MA, Correa M, Salamone JD.
    Neuropsychopharmacology; 2016 Feb 10; 41(3):686-94. PubMed ID: 26105139
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Monoamine oxidase-inhibition and MPTP-induced neurotoxicity in the non-human primate: comparison of rasagiline (TVP 1012) with selegiline.
    Kupsch A, Sautter J, Götz ME, Breithaupt W, Schwarz J, Youdim MB, Riederer P, Gerlach M, Oertel WH.
    J Neural Transm (Vienna); 2001 Feb 10; 108(8-9):985-1009. PubMed ID: 11716151
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [History of deprenyl--the first selective inhibitor of monoamine oxidase type B].
    Knoll J.
    Vopr Med Khim; 1997 Feb 10; 43(6):482-93. PubMed ID: 9503565
    [Abstract] [Full Text] [Related]

  • 15. The effects of L-deprenyl treatment, alone and combined with GM1 ganglioside, on striatal dopamine content and substantia nigra pars compacta neurons.
    Rothblat DS, Schneider JS.
    Brain Res; 1998 Jan 01; 779(1-2):226-30. PubMed ID: 9473679
    [Abstract] [Full Text] [Related]

  • 16. Selective inhibition of MAO-B through chronic low-dose (R)-deprenyl treatment in C57BL/6 mice has no effect on basal neostriatal dopamine levels.
    Steyn SJ, Castagnoli K, Steyn S, Castagnoli N.
    Exp Neurol; 2001 Apr 01; 168(2):434-6. PubMed ID: 11259132
    [Abstract] [Full Text] [Related]

  • 17. Rat striatal monoamine oxidase-B inhibition by l-deprenyl and rasagiline: its relationship to 2-phenylethylamine-induced stereotypy and Parkinson's disease.
    Youdim MB, Tipton KF.
    Parkinsonism Relat Disord; 2002 Mar 01; 8(4):247-53. PubMed ID: 12039419
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effects of the adenosine A 2A antagonist KW 6002 (istradefylline) on pimozide-induced oral tremor and striatal c-Fos expression: comparisons with the muscarinic antagonist tropicamide.
    Betz AJ, Vontell R, Valenta J, Worden L, Sink KS, Font L, Correa M, Sager TN, Salamone JD.
    Neuroscience; 2009 Sep 29; 163(1):97-108. PubMed ID: 19467297
    [Abstract] [Full Text] [Related]

  • 20. Effects of tetrabenazine on methamphetamine-induced hyperactivity in mice are dependent on order and time-course of administration.
    Kuribara H.
    Pharmacol Biochem Behav; 1997 Jan 29; 56(1):9-14. PubMed ID: 8981603
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.